These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6193695)

  • 1. BRL 22321, a compound that has mast cell stabilizing activity similar to that of disodium cromoglycate and in addition has smooth muscle relaxing activity.
    Spicer BA; Ross JW; Clarke GD; Harling EJ; Hassall PA; Smith H; Taylor JF
    Agents Actions; 1983 Jun; 13(4):301-9. PubMed ID: 6193695
    [No Abstract]   [Full Text] [Related]  

  • 2. A protective action of disodium cromoglycate against the contraction of guinea-pig ileum induced by various pharmacological stimulants.
    Kazimierczak W; Gonzalez Alvarez R; Maśliński C
    Agents Actions; 1980 Apr; 10(1 Pt 2):8-14. PubMed ID: 6155773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRL 22321. A compound with similarities to both disodium cromoglycate and theophylline.
    Smith H; Ross JW; Spicer BA; Clarke GD; Harling EJ; Hassall PA; Taylor JF
    Monogr Allergy; 1983; 18():223-5. PubMed ID: 6196629
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of formoterol (BD 40A), a beta-adrenoceptor stimulant, on isolated guinea-pig lung parenchymal strips and antigen-induced SRS-A release in rats.
    Tomioka K; Yamada T; Tachikawa S
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):91-102. PubMed ID: 6202254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo activity profile of RHC 2851: a new orally effective antiallergic agent.
    Khandwala A; Carlson R; Dally-Meade V; Donigi-Ruzza D
    J Immunopharmacol; 1983; 5(4):311-32. PubMed ID: 6199431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue.
    Butchers PR; Fullarton JR; Skidmore IF; Thompson LE; Vardey CJ; Wheeldon A
    Br J Pharmacol; 1979 Sep; 67(1):23-32. PubMed ID: 115530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mode of action and indication for disodium cromoglycate (DSCG).
    Kunkel G; Baumer FE; Okuda M; van Cauwenberge P
    Allergol Immunopathol (Madr); 1985; 13(4):285-9. PubMed ID: 2417468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiallergic action of disodium cromoglycate and xanthone RS 7540.
    Gonzalez Alvarez R; Kazimierczak W
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):333-9. PubMed ID: 6135406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of HSR-6071, a new anti-allergic agent, on experimental asthma in rats and guinea-pigs.
    Makino E; Ohashi T; Takahashi H; Kato H; Ito Y; Nagai H; Koda A; Azuma H
    J Pharm Pharmacol; 1990 Apr; 42(4):236-41. PubMed ID: 1974289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of ascorbic acid and disodium cromoglycate in some models of experimental anaphylaxis.
    González RG; García M; Pérez Saad H; de la Vega AR
    Allergol Immunopathol (Madr); 1979; 7(3):211-6. PubMed ID: 89807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New light on the mechanism of action of disodium cromoglycate.
    Alvarez RG; Kazimierczak W
    Agents Actions; 1981 Apr; 11(1-2):94-6. PubMed ID: 6787851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. II. Comparison of RHC 3164 with disodium cromoglycate.
    Khandwala A; Dally-Meade V; Jariwala N; Huang F
    Int Arch Allergy Appl Immunol; 1984; 73(1):65-70. PubMed ID: 6198288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the inhibition of phosphodiesterase activity and allergic histamine release by disodium cromoglycate and compound I.C.I. 74917.
    Barrett-Bee K; Henderson W
    Biochem Soc Trans; 1976; 4(4):699-701. PubMed ID: 63402
    [No Abstract]   [Full Text] [Related]  

  • 14. Potent inhibitory activity of HSR-6071, a new antiallergic agent, on passive cutaneous anaphylaxis (PCA).
    Makino E; Ohashi T; Takahashi H; Kato H; Ito Y; Nagai H; Koda A; Azuma H
    Jpn J Pharmacol; 1990 Jan; 52(1):87-94. PubMed ID: 1689783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological activity of biscoumarinoxy-, bis(1,2-benzisoxazoloxy) & bisbenzofuranoxy-alkanes & their unsymmetric compounds: disodium cromoglycate analogs.
    Thakar KA; Dumir AB
    Indian J Exp Biol; 1978 Jun; 16(6):732-4. PubMed ID: 81180
    [No Abstract]   [Full Text] [Related]  

  • 16. Extracellular guanosine 3',5'-cyclic monophosphate and disodium cromoglycate share a similar spectrum of activity in the inhibition of histamine release from isolated mast cells and basophils.
    Mackay GA; Pearce FL
    Int Arch Allergy Immunol; 1996 Mar; 109(3):258-65. PubMed ID: 8620095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
    Nabe T; Yamamura H; Kohno S; Ohata K
    Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual modes of action for disodium cromoglycate in inhibition of antigen-induced contractions of guinea-pig isolated airways smooth muscle.
    Stewart AG; Fennessy MR
    Clin Exp Pharmacol Physiol; 1983; 10(5):595-603. PubMed ID: 6416724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibition by disodium cromoglycate in vitro of anaphylactically induced histamine release from rat peritoneal mast cells.
    Kusner EJ; Dubnick B; Herzig DJ
    J Pharmacol Exp Ther; 1973 Jan; 184(1):41-6. PubMed ID: 4119619
    [No Abstract]   [Full Text] [Related]  

  • 20. The novel marine natural product plocamadiene A causes histamine release from mast cells of the guinea-pig and rat in vitro.
    Thomas SG; Beveridge AA
    Clin Exp Pharmacol Physiol; 1993 Apr; 20(4):223-9. PubMed ID: 7683592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.